BRYANT WARREN F

Director Bryant Warren F bought 1,000 shares at blended avg $80.82 on 2024-09-10; stock down 48.4% from 52-week high of $161.22.

Bryant Warren F, a Dollar General director, executed 2 separate purchases totaling 1,000 shares for $80,825.00 on 2024-09-10 at prices of $80.50 and $81.15, increasing his stake from 41,030 to 42,030 shares (+2.4%). The timing is noteworthy: the purchase occurred at $80.82 while the stock has since declined to $83.21 (within the 52-week range of $80.41–$161.22). Critically, DG stock is down 48.4% from its 52-week high and down 28.8% over the past 30 days, placing this transaction near the lower bound of recent valuations. His prior trades at Dollar General (2 on 2023-12-15) both showed +15.3% 90-day returns; however, his most recent DG purchase on 2024-09-05 remains unmeasured, and the cross-ticker track record (100.00% win rate over 90 days, +15.3% avg return) describes a longer history across multiple securities. The magnitude of this directional bet—a 2.4% position increase—signals sustained confidence during material price pressure, though the pattern does not yet establish whether this represents a reversal inflection or continued margin compression in the business (revenue growth of +2.2% YoY, P/E 12.92).

Director Warren F. Bryant buys 500 DG shares at $80.40 amid -49.8% decline from 52-week high; prior same-ticker buys showed +15.3% 90d returns.

Warren F. Bryant, a Director at Dollar General, purchased 500 shares at $80.40 on 2024-09-05, bringing his total holdings to 41,030 shares. This purchase occurs while DG trades -49.8% below its 52-week high of $161.22 and -30.7% lower over the past 30 days. Notably, Bryant's two prior open-market purchases at this ticker (both on 2023-12-15) each realized +15.3% gains over 90 days, a timing pattern his cross-ticker track record reinforces with a 100% 90-day win rate across 2 prior buys averaging +15.3% 90d returns. The current transaction adds 1.2% to his existing position, suggesting incremental accumulation rather than a concentrated bet. Investors should monitor whether this purchase precedes recovery in a stock that has experienced material recent depreciation.